LPA rs55730499: What Your Genotype Means
The rs55730499 variant is a single-nucleotide polymorphism located within the LPA gene, which encodes apolipoprotein(a). Carrying the protective alternate allele is associated with lower circulating levels of lipoprotein(a), reduced susceptibility to coronary artery disease, and extended parental attained age and overall healthspan. However, because longevity is polygenic and environmental factors play a major role, this variant represents a modest shift in statistical probability rather than a definitive predictor of lifespan.
What each genotype means
Typical lipoprotein(a) profile
This is the most common genotype for this variant. Research indicates that individuals with this genotype do not carry the specific genetic variation associated with lower circulating lipoprotein(a) levels and extended healthspan.
This is the most frequent genotype, carried by the vast majority of individuals in most populations.
Potential longevity-associated profile
Carrying one copy of the T allele is associated with lower circulating levels of lipoprotein(a). Some studies suggest this genetic profile may be linked to extended parental attained age and improved healthspan, though the evidence remains limited.
The T allele is a minor allele with a frequency of approximately 3-7% in European populations, making this heterozygous genotype relatively uncommon.
Enhanced longevity-associated profile
Carrying two copies of the T allele is associated with a more pronounced reduction in circulating lipoprotein(a) levels compared to those without the variant. While this is linked to potential benefits for healthspan and longevity, these associations are based on statistical population studies and do not guarantee individual health outcomes.
This homozygous genotype is rare, occurring in a very small fraction of the population given the low frequency of the T allele.
Genomic Location and the Nature of the Variant
The single-nucleotide polymorphism rs55730499 is situated within the LPA gene on chromosome 6. Cataloged as an intronic and splice-altering variant, it influences pre-mRNA processing and expression of the apolipoprotein(a) transcript. In genetic research, variations at this locus frequently correlate with differences in circulating lipoprotein(a) particles in the bloodstream. While the standard reference allele is associated with baseline lipid production, the alternate protective allele disrupts standard transcript processing, leading to decreased synthesis or secretion of the mature protein. Variants within LPA are often studied alongside structural copy number variants, such as kringle IV type 2 (KIV-2) repeats, which also heavily regulate plasma concentrations. Because rs55730499 resides within this complex locus, researchers use genome-wide sequencing and genotyping arrays to isolate its specific contribution to cardiovascular phenotypes and human aging.
The Biological Role of the LPA Gene
The LPA gene provides the blueprint for apolipoprotein(a), a specialized glycoprotein that covalently binds to an LDL-like particle via a disulfide bond to form lipoprotein(a), commonly abbreviated as Lp(a). Unlike typical low-density lipoprotein (LDL) cholesterol, Lp(a) possesses structural homologies to plasminogen, which contributes to both pro-atherosclerotic and pro-thrombotic mechanisms. Elevated concentrations of Lp(a) promote inflammation, accelerate the deposition of cholesterol within arterial walls, and increase the likelihood of atherosclerotic plaque rupture. Circulating concentrations of Lp(a) are predominantly genetically determined, with diet and lifestyle having little impact compared to standard lipid fractions. Consequently, genetic variations within LPA that naturally depress protein expression lead to life-long reductions in circulating Lp(a), thereby providing an innate, lifetime reduction in vascular lipid deposition and associated inflammatory stresses.
Evidence for Longevity, Healthspan, and Cardiovascular Protection
A substantial body of research connects LPA variants to cardiometabolic disease and healthspan outcomes. Large biobank analyses, including extensive studies in the UK Biobank involving hundreds of thousands of participants, have identified rs55730499 as a major locus linked with both coronary artery disease and parental attained age. In these epidemiological models, alleles that reduce circulating Lp(a) levels and lower vascular risk show significant genome-wide associations with surviving to older ages and remaining free from early-onset cardiometabolic morbidity. However, the evidence strength for direct healthspan extension remains graded as limited to moderate. Because parental longevity reflects a composite trait influenced by thousands of genetic variants and lifestyle variables, carrying the protective allele provides a modest shift in statistical odds rather than a guarantee of longevity. Research in non-European ancestries also remains limited.
Clinical Interpretation and Limitations
Knowledge of an individual's rs55730499 genotype should be contextualized carefully. While commercial genetic panels may report this SNP under longevity or cardiovascular categories, genetic data alone cannot substitute for direct biomarker evaluation. A person carrying the protective allele might still exhibit elevated Lp(a) or higher overall cardiovascular risk due to KIV-2 repeat variations, familial hypercholesterolemia mutations, diet, smoking, or other factors. Furthermore, genetics should never prompt self-directed changes in preventative medications or lipid-lowering therapies. Standard clinical guidelines emphasize comprehensive risk assessment, including traditional lipid panels and direct quantification of serum Lp(a) when indicated. Patients interested in how their genetic background intersects with heart health or family history should discuss their profile with a qualified physician or cardiovascular genetic counselor.
How common is this variant?
The minor protective allele has an observed frequency of roughly 3% to 8% in individuals of European ancestry, with the homozygous minor genotype occurring in less than 1% of the population. Data regarding allele distribution and effect sizes in non-European ancestries remain limited in published biobank cohorts.
Frequently asked questions
Does having the protective rs55730499 allele guarantee a longer life?
No. While studies associate this allele with extended parental survival and reduced heart disease rates, overall longevity is shaped by thousands of interacting genes, lifestyle behaviors, and environment. The allele confers a statistical advantage rather than a deterministic outcome.
Can this genetic test replace a standard lipoprotein(a) blood test?
No, genetic testing for rs55730499 does not replace direct laboratory measurement. Plasma lipoprotein(a) levels are determined by complex genetic interactions, including KIV-2 domain repeats, meaning direct blood tests are necessary to assess actual protein concentrations.
Can diet or exercise change how this variant affects lipoprotein(a)?
Circulating lipoprotein(a) concentrations are largely fixed by genetics and show minimal variation in response to diet, exercise, or lifestyle changes. However, maintaining a healthy lifestyle remains critical because it mitigates other modifiable cardiovascular risk factors such as LDL cholesterol and blood pressure.
What should I do if my test shows the common or higher-risk genotype?
Having the standard genotype simply means you lack this specific protective variation, which is true for the vast majority of people. You should consult a medical provider to evaluate your overall cardiovascular risk using established clinical tools and family history.
Sources & further reading
Educational information only, last refreshed 9/8/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs55730499?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in LPA
This variant in the LPA gene elevates serum lipoprotein(a) levels, significantly increasing the risk of coronary atherosclerosis and aortic stenosis.
Variant in the LPA gene locus associated with circulating lipoprotein(a) levels and cardiovascular healthspan.
Intronic splice-affecting variant in LPA leading to elevated plasma lipoprotein(a) concentrations and increased risk of aortic valve stenosis and coronary disease.
Intronic variant in LPA strongly associated with elevated circulating lipoprotein(a) levels and increased risk for coronary artery disease and aortic stenosis.
This variant is strongly associated with significantly elevated levels of Lipoprotein(a), a major independent risk factor for heart disease.
An LPA-locus variant identified as an independent genetic determinant of human healthspan and disease-free survival through modulated cardiovascular risk.